Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Device Firms Need More Help Making Direct-To-Consumer “Brief Statements”

This article was originally published in The Gray Sheet

Executive Summary

Device manufacturers should be given the opportunity to have FDA review their direct-to-consumer ads for restricted devices before they go public, according to AdvaMed
Advertisement

Related Content

Device Firms Under Pressure To Add More Warnings To DTC Ads
Device Firms Under Pressure To Add More Warnings To DTC Ads
Device Firms Go Direct To Consumers Amid Physician Skepticism
Device Firms Go Direct To Consumers Amid Physician Skepticism
DTC Ads, Third-Party Audits Are CDRH Compliance Office Priorities In 2006
DTC Ads, Third-Party Audits Are CDRH Compliance Office Priorities In 2006
DTC Guidances Need Added Focus On Device-Specific Issues – AdvaMed
DTC Guidances Need Added Focus On Device-Specific Issues – AdvaMed
Advertisement
UsernamePublicRestriction

Register

MT022859

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel